Professional Documents
Culture Documents
Ok Hi Rekap
Ok Hi Rekap
Ok Hi Rekap
9 1/11/2021 Mrs.DAR/29YO/1194662/
04.04.21 Mrs.IND/22YO/1202465/DID-IZY-HUD/HD
05.04.21 Mrs. SAR/ 25 YO/ 1202613/ OGAN KOMERING ILIR/ STI-NAL/ KY
05.04.21 Mrs. KHO/ 32 YO/ 1192019/ BANYUASIN/ ZAN/ NS
05.04.21 Mrs. ANI/ 31 YO/ 1179919/ PALEMBANG/ IKY-PIT/ AB
05.04.21 Mrs.MEI/ 31 YO/ 1024319
MEI
MEI Ms. NAB/ 21 YO/ 1202332/ PALEMBANG/ STI-NAL/ HI
Mrs. FIT/ 45 YO/ 1202383/ BANYUASIN/ DID-WIS/ HE
MEI
Mrs. END/ 24 YO/ 1202396/ PALEMBANG/ DID-WIS/ HD
MEI
Mrs. IST/37 YO/1200520/OKU Timur/STI-OSP/PB
MEI
Mrs. SRI/34 YO/1202412/Palembang/STI-OSP/HD
MEI
Mrs. HAN/ 25 YO/ 1202586/ BANYUASIN/ STI-TIA/ AB
MEI
Mrs. Maya Wulan Sari/ 36 YO/ 12017176/ PALEMBANG/ STI-TIA-VAI/ FY
MEI
Mrs. PAR/33 YO/1200521/Palembang/P3A2/MUT-IJA/HE
MEI
Mrs. KHO/ 32 YO/ 1192019/ BANYUASIN/ ZAN/ NS
MEI
JUNI Mrs. UMI/ 19 YO/ 1202717/ PALEMBANG/DEV-WAH/AW
JUNI
Mrs. SUR/30 YO/ 1203264/ BANYUASIN/ STI-WAH/ FB
JUNI
Mrs. WAY/ 31 YO/ 1203425/ OGAN KOMERING ULU TIMUR/ API-WIS/ AB
early post partum hemorrhage caused by rest of placenta and vaginal laceration
Severe anemia
G1P0A0 37 weeks gestational age not in labor
Premature rupture of membrane 12 hours
Single life fetus cephalic presentation
Anhydramnios
G3P2A0 37 weeks gestational age not in labor
Severe preeclampsia
Covid-19 was suspected ( pneumonia)
Single life fetus cephalic presentation
G2P1A0 38 weeks gestational age second stage labor
Single life fetus breech presentation
G1P0A0 30 weeks gestational age in labor first stage active phase
Preterm Premature rupture of membrane 2 hours
Twin life fetus
• Perineal cephalic
laceration presentation
grade III A breech presentation
Mild anemia infection
• Intrauterine
Single 19
• Covid lifewas
fetus cephalic (IgG
suspected presentation
reactive)
Single life anemia
• Moderate fetus cephalic presentation
(microcytic hypochrome)
Single live
• Severe fetus cephalic presentation
preeclampsia
•Post
Single life fetus cephalic presentation
operative diagnosis
•P2A0 post
Single lifeLSCS oi post-term
fetus Cephalic pregnancy
presentation
• Anhydramnios
Moderate anemia
• Single life fetus cephalic presentation
breech presentation
Severelife
• Single bilateral ventriculomegaly
fetus cephalic + meningocele + dolicocephali
presentation
•· Asymptomatic
Fetal tend to beUTI small
Single life
· PROM fetus cephalic presentation
1 days
Syphylis
· UTI infection was suspected
asymptomatics
· Single life fetus cephalic presentation
Polyhydramnios
· Atresia Esofaghial was supeted
G2P1A0 37 weeks gestational
• Early postpartum age second
haemorrhagic causedstage of laborlaceration
by obstetric with Retention of second b
of cervix
• Severe
Diabetes Anemia
mellitus type II uncontrolled
• Single life fetus cephalic presentation
Macrosomia
• Late postpartum was suspected
hemorrhage cb rest of placenta
•Asymptomatic
Severe anemiaurinary infection
• Singlelife
Single fetusfetus
death cephalic presentation
cephalic presentation (O34.6)
• Congenital anomaly (Q79.2)
G2P1A0 39 weeks gestational age not in labor
COVID-19 was suspected
Single life fetus transverse lie
G3P2A0 37 weeks gestational age not in labor
Prior CS 1x (on indication failed of induction)
Premature rupture of membrane 2 hours
Hepatitis B infection
COVID-19 was suspected
Single life fetus breech presentation
Oligohydramnios
G1P0A0 37 weeks gestational age not in labor
Premature rupture of Membrane 15 hours
Single life fetus cephalic presentation
Anhydramnios
G1P0A0 37 weeks gestational age not in labor
Impending eclampsia
Single life fetus cephalic presentation
G3P2A0 40 weeks gestational age in labor first stage latent phase
Severe preeclampsia
Prior CS 2x
Single life fetus cephalic presentation
G1P0A0 37 weeks gestational age not in labor
Premature rupture of membrane 12 hours
Single life fetus cephalic presentation
Anhydramnios
Status : Stable in ward
Status : Stable in ward
G2P1A0 37 weeks gestational age not in single life fetus cephalic presentation with meningoencephalocele
Prior CS 1x on indication severe preeclampsia
Diabetes mellitus type II
SLF cephalic presentation
Utero Placental hypoperfusion
DISCHARGED
Covid 19 Was suspected (U07.1)
Single life fetus intrauterine (Z21.0
G1P0A0 33 weeks gestational age (Z3A.33)
Threatened preterm labor ( O47)
Asymptomatic
G2P1A0 Urinary
39 weeks Tract age
gestational Infection
not in labor (Z3A.39)
Prior CS 1x (on indication fetal distress) (O34.21)
Covid-19 was suspected ( IgG reactive) (U07.2)
Single
G1P0A0 life38fetus cephalic
weeks presentation
gestational age not (Z37.0)
in labor (Z3A.37)
PROM 8 35
G2P0A1 hours (O42.10)
weeks gestational age not in labor (Z3A.35)
Severe preeclampsia (O14.1)
Uterine Myoma
Prior
G2P0A1CS 38
(oiweeks
Uterine Myoma) age in labor with prolonged second stage (Z3A.38)
gestational
Cephalopelvic disproportion was suspected ( O65.4)
Single life fetus cephalic presentation ( Z37.0)
G4P2A1 38 weeks gestational age in labor 1st stage latent phase ( Z3A.38)
Prior CS 1x (o.i postterm) (O34.21)
COVID-19 was suspected (U07.2)
Single
G1P0A0 life38fetus tranverse
weeks lie (Z34.0)
gestational age not in labor ( Z3A.38)
Severe preeclampsia (O14.13)
PROM 1 day (O42.1)
Intrauterine infection
G2P1A0 35 weeks was suspected
gestational age not in labor
Prior CS 1x ( on indication failed induction)
Obs. Dyspneu caused by pneumonia was suspected caused by Covid-19 was suspected (antigen swab SARS Co
Maternal distress
G3P2A0 38 weeks gestational age not in labor ( Z3A.38)
Prior CS 2x ( O34.21)
Single life fetus cephalic presentation
G6P3A2 38 weeks gestational age not in labor (Z3A.38) with Hepatitis B infection (070.20)
Single life fetus cephalic persentation
Post op diagnosis:
P4A2
P3A0 post
post LSCS on indication
spontaneous Hepatitis
expulsion (O03.9)B infection
History of ROM 3 days (O42.0)
Acute myeloblastic leukemia (C92.00)
G1P0A0 40 weeks gestational age not in labor (Z3A.40)
Premature rupture of membrane 1 day ( O44.012)
Asymptomatic urinary tract infection ( N13.2)
Single
G3P2A0 life39fetus cephalic
weeks presentation
gestational ( Z37.0)
age inlabor first stage latent phase (Z3A.39)
Complete placenta previa (O44.10)
Prior CS 1x ( on indication umbilical cord entanglement) ( O34.21)
PASD
G2P1A0was
39suspected (O43.21)age inlabor second stage (Z3A.39)
weeks gestational
Severe preeclampsia (O14.1)
Covid 19 was suspected (U07.2)
Recent Diagnosis
Single life fetus cephalic presentation
P3A1 Post LSCS on indication anhydramnios
history of ROM 1day
·Single life fetus cephalic presentation ( Z37.0)
Recent diagnosis
•P4A0 postLSCS
P3A0 Post LSCSono.iindication
Prior CS prior
3x CS 2x
Post pomeroys tubectomy
COVID1-9 was suspected
Covid 19 confirmed (U07.1)
Post
IUFDTubectomy pomeroy (66.1)
Covid-19 infection was suspected
P1A0 post spontaneous delivery
Covid 19 Confirmed
Recent diagnosis
P1A0 preterm spontaneous delivery
Post curettage on indication rest of placenta
P1A0 post spontaneous delivery 2 hours (outside)
Post brand Andrew manuver on indication incarcerated of placentae
Oligohydramnios
Multiple uterine myoma
Recent diagnosis
P2A0 post anemia
Moderate LSCS on indication prior CS 1x + interdelivery <18 months
Covid-19 confirmed (U07.1)
P3A0 post spontaneous delivery 6 days (outside)
Post curettage on indication rest of placenta (O73.0)
P3A0 Post LSCS oi Anhydramion and Premature rupture of membrane 2 days (O44.10)
Probable Covid 19 confirmed (U07.1)
P1A1 post spontaneous delivery
Covid-19 was confirmed
P2A0 Post SLCS o.i prior CS 1 time with interdelivery 12 months + history of myomectomy + fetal distress
Covid 19 was suspected
Solid ovarian neoplasm with malignancy was suspected dd/ uterine sarcoma + diabe
Recurrent endometriosis cyst
Right endometriosis cyst + primary infertile 12 years
Dysmenorrhea caused by bilateral endometriosis cyst + primary infertile 1,5 years
Dysmenorrhea caused by right endometriosis cyst + primary infertile 2 years
Cystic ovarian neoplasm with malignancy was suspected
Solid ovarian neoplasm with cystic part
Multilocular cystic ovarian neoplasm with malignancy was suspected
Abnormal uterine bleeding caused by uterine adenomyosis + uterine myoma
Uterine sarcoma was suspected + malformation CCV
Multilocular cystic ovarian neoplasm with malignancy was suspected
G2P1A0 39 weeks gestational age not in labor with prior CS 1x + CPD was suspect
Subserous uterine myoma
Solid ovarian neoplasm + AKI Stage II + right limb DVT
Cystic ovarian neoplasm with malignancy was suspected
•Twin life fetus breech-breech presentation
•G1P0A0 37 weeks gestational age not in labor (Z3A.37)
•Premature rupture of membrane 3 hours (O44.02)
•Hepatitis B Infection (B18.9)
•SLF cephalic presentation
•G3P2A0 39 weeks gestational age first stage in labor latent phase (Z3A.39)
•Prior CS 2x inter-delivery interval 11 months (O34.21)
•Moderate anemia (O99.01)
•Twin life fetus
Multilocular breech-breech
cystic presentation
ovarian neoplasm with malignancy was suspected ( C56.9)
Uterine corpus was ssupsected ( C51.9)
Urinary tract infection ( N39.0)
307
277
30
Tindakan
LSCS
LSCS
Tubectomy Pomeroy
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS + tubectomy pomeroy
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS + Histerectomy
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS + Histerectomy
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS
LSCS (741)
LSCS
LSCS
Hysteroscopy D&C
LSCS
LSCS (74.1)
LSCS
LSCS
LSCS (74.1)
LSCS (74.1)
LSCS (74.1) + Tuba Ligation
LSCS (74.1)
LSCS (74.1)
Laboratory examination
Plan
LSCSelective
(74.1) LSCS + tubectomy pomeroy
Tubectomy pomeroy (66.62)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
Tubal ligation
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1) + Tubectomy pomeroy
(66.62)
LSCS (74.1)
Cerclage (67.51)
LSCS
LSCS
LSCS
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
Tubectomy pomeroy (66.62)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
LSCS (74.1)
lscs
lscs
Laparotomy FS ( 54.1)
Laparotomy surgical staging ( 54.1)
Antibiotic ( 99.21)
LSCS (74.1)
•Myomectomy
•Adhesiolysis
•Adenomyosis resection
•B-Lynch
uterine myoma
LSCS (74.1)
•Myomectomy
•Adhesiolysis
•Adenomyosis resection
B-Lynch
uterine myoma
LSCS (74.1)
LSCS (74.1)
Tubectomy Pomeroy
Hysteroscopy DnC
hysterectomy
Laparoscopy operative
Laparoscopy operative
2nd baby + severe preeclampsia
LSCS (74.1)
Tubectomy Pomeroy
LSCS (74.1)
rate) (O76)
LSCS (74.1)
LSCS (74.1)
al cerclage removal
•LSCS ( 74.21)
Mrs. END/ 38 YO
Mrs. EMI/39 YO/1196412/Bengkulu/P2A0/AF-HD
HIL-SAR
FEBRUARI Mrs.
WIS KOR/ 29 YO/ 1200818/ Palembang/
THR
FB
WIS MAR/ 39 YO/ 1200339/ Palembang/ AT-HE
Mrs.
Mrs. EFE/ 40 YO/ 1113077/ Palembang/ RK-AC
Mrs. MAR/ 61 YO/ 1201232/ Muara Enim/ P3A0/ AF-HD/ ARM
Mrs. MAY/ 51 YO/ 1200336/ Bangka Belitung/ P2A0/ AT-HE/ MUT
Miss.MAS
Mrs. RAN// 34
54 YO/ 1203488/
1197749/ PALEMBAN
PALEMBANG/ IS/ MUT-RAM
Mrs. KAM/ 48 YO/ 1181897/ Palembang/ P2A3/ AT-HE/ IJA-INO
SEPTEMBER TAT/69
Mrs. She/ YO/1198420/OI
30 YO/1211356/ P0A0/ Palembang
SEPTEMBER
SEPTEMBER Mrs. DEB/ 29 YO/ 1209694 / OKU TIMU
Mrs. DIA/ 53 YO/ 1197151/P3A0/ Palembang/ KY - HIL
SEPTEMBER
SEPTEMBER Mrs. ERN/65 YO/ 1202849/ PALEMBANG/
Mrs. DER/ 33 YO/ 805564/ Palembang/
NAL-HE-AT
SEPTEMBER
SEPTEMBER Mrs. WIW/ 34 YO/ 835176/ PALEMBANG
SEPTEMBER Mrs. HEL/ 54 YO/ 31527/ PALEMBANG/
SEPTEMBER Mrs. EMM/ 47 YO/ 1203286/ BANGKA BE
Preoperative Diagnosis:
Right endometriosis cystVesico-utero-cervico-vaginal
(N80.1) Fistula (N82.0)
Left cystic ovarian neoplasm (D27.9)
Post
Post menopause
laparoscopybleeding causedoiby
myomectomy malignancy
multiple was suspected
intramural (N85.00)
and subserous uterine myom
Post laparoscopy adhesiolysis on indication internal genitalia adhesion
Bilateral patent tubes
Post laparoscopy total hysterectomy
Post laparoscopy rectovaginal nodule resection
Post laparoscopy adhesiolysis
Cystic
Post ovarian neoplasm
Operative Diagnosis:malignancy was suspected ( C56)
Ovarian cancer
Diabetes clinically
Mellitus type II stage IIIC
Multiloculare cystic ovarian neoplasm with malignancy was suspected ( C56)
Ovarian premature
Preterm cancer inadequate
rupturestaging
of membrane 1 day
Single
LGSIL life fetus cephalic presentation Anhydramnios
Submucous uterine
Diabetes mellitus myoma
type II
Recurrent ( C56.9)
Ovarian cancer Moderate anemia ( D64.9)
GIN was suspected (O01.9)
Left multilocular cystic ovarian neoplasm dd/ left rubrum corpus ( N83.02)
Left multilocular cystic ovarian neoplasm dd/ left rubrum corpus ( N83.02)
Cervical cancer Stage IIIB complete therapy (C53.9)
Stage IIIB (C53.9)
Cervical cancer Moderate anemia ( D64.9)
Solid ovarian neoplasm with cystic part, malignancy was suspected (C56)
Pedunculated Myoma (D25.0)
Endometrial Hyperplasia
Dysmenorrhea (N85.0)
caused by right endometriosis cyst (N80.0)
Right tubal Endometriosis (N80.2)
Stage IIIB ( C53.9)
Moderate
Stage IIIB anemia
complete( D64.9)
therapy complete response ( C53.9)
Hypoalbuminemia (E88.09)
•Intramural uterine myoma (D25.1)
Cervical cancer III B
•Left cyst ovarian neoplasm (C56.9)
•Primary
Cystic infertile
ovarian
Thrombocytopenia 1,5
neoplasm years
with
( D69.6) (N97.9)
solid part, permagna, malignancy was suspected (
Bilateral intramural
Multiple solid ovarian neoplasm
and with
subserous cysticmyoma
uterine part dd/(D25.9)
non-gynecology mass
Solid ovarian neoplasm with cyst part malignancy was suspected (D27.9)
Mild anemia (D64.9)
HHD NYHA
Right I (I11. 0)
patent tube
-Abnormal
Bilateral uterine
patent bleeding cause by endometrial polyp was suspected (N93.9)
tubes
-Adenomyosis was suspected (N800)
Post op diagnosis: Cervical cancer stage IIA (C53)
ICD 10
C56.9 ovarian
Cystic Malignant neoplasm
neoplasm of solid
with rightpart
ovary
malignancy was suspected ( C56.9)
Right endometriosis cyst (N80.1)
Left cystic ovarian neoplasm (D27.9)
Cystic ovarian neoplasm with solid part, malignancy was suspected
AUB c.b A1
•(N80.0)
•Endometriosis of uterus
Cervical cancer stage IIIB
Hypoglycemia
Laparotomy
Laparotomy myomectomy
laparoscopy myomectomy
Laparoscopy
Laparoscopy
Adhesiolysis
Resection adenomyosis
Laparoscopy
laparatomy
laparatomy
Adhesiolysis (54.51)
Stab wound drain
Laparotomy VC ( 54.1)
Omentectomy
Laparoscopy total Hysterectomy (68.41)
Bilateral salpingoooforectomy (65.6)
Laparotomy
·AdhesiolysisVC ( 54.1)
·Stab Wound drain
Laparotomy VC
Laparotomy VC
Laparotomy VC
Laparotomy hysterectomy
Laparotomy hysterectomy
Tubectomy pomeroy
Laparotomy VC
Laparotomy radical hysterectomy
Laparotomy VC
Laparotomy VC
Laparotomy hysterectomy
Laparotomy surgical staging
LSCS
Laparotomy Surgical staging/ VC
Laparoscopy myomectomy
Laparotomy hysterectomy
laparoscopy diagnostic
Laparotomy unilateral – salpingo-oophorectomy
Laparotomy VC
Laparotomy hysterectomy
LSCS
Laparotomy surgical staging
Laparotomy second look
CIM Chemotherapy 1ft course
( 99.25)
Plan for radiotherapy ( 92.29)
Chemotherapy paclitaxel-carboplatin
1ft course ( 99.25)
Plan for radiotherapy ( 92.29)
Chemotherapy paclitaxel-carboplatin
1ft course ( 99.25)
Plan for radiotherapy ( 92.29)
CIM Chemotherapy 3rd course
( 99.25)
Plan for CT Simulation ( September,
24th 2021) ( 92.29)
Chemotherapy paclitaxel-carboplatin
4th course ( 99.25)
Hospitalized
PRC Transfusion ( 99.04)
Leucogen injection ( 99.21)
Chemotherapy paclitaxel-carboplatin
5th course ( 99.25)
Hospitalized
PRC Transfusion ( 99.04)
BEP chemotherapy 3rd course
( 99.25)
ß-Hcg evaluation ( V62.4)
Laparotomy FS ( 54.1)
Laparotomy FS ( 54.1)
Pap smear evaluation 3 month later
Hospitalized
PRC Transfusion ( 99.04)
Plan for radiation ( 92.29)
Hospitalized
PRC Transfusion ( 99.04)
Chemotherapy paclitaxel-carboplatin
5th course ( 99.25)
Plan for CT Simulation ( July, 12th
2021) ( 92.29)
Chemotherapy paclitaxel-carboplatin
3rd course ( 99.25)
ß-evaluation 1 month later ( V62.4)
Laparotomy FS ( 54.1)
Laparotomy debulking( 54.1)
Joint op with digestive surgery
Laparotomy FS ( 54.1)
Hospitalized
PRC Transfusion ( 99.04)
Chemotherapy paclitaxel-carboplatin
3rd course ( 99.25)
Plan for CT Simulation ( August, 12th
2021) ( 92.29)
Pap smear evaluation 1 month later
•Total vaginal hysterectomy (68.59)
•Anterior
•Repair of colporrhaphy
vaginal stump(70.51)
(70)
Hysteroscopy D & C
Laparotomy VC
Laparoscopy cystectomy
Laparotomy VC
Laparotomy VC
Laparotomy surgical stagING
Laparotomy myomectomy
Laparotomy
Laparotomy VC
Hysteroscopy diagnostic
Laparoscopy cystectomy
Laparotomy
Laparotomi surgical
Hysterectomy
Laparotomy VC ( 54.1)
Laparoscopy bilateral cystectomy
Laparotomy
Laparoscopy operative:
Hysteroscopy
• Laboratory examination (V72.62)
• Lung maturation (659.8)
• Tocolytic (644.03)
• Obstetric ultrasound (75.99)
Hysteroscopy DnC
HDLO
Laparoscopy hysterectomy
"HDLO
"
"Laparoscopy operative
"
Laparoscopy operative
"Laparoscopy operative
"